Mary Beth Terry

发表

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository

Rosemary L. Balleine, Christine L. Clarke, D. Gareth Evans, 2014 .

The use of multiple imputation in molecular epidemiologic studies assessing interaction effects

Mary Beth Terry, Manisha Desai, Marilie D. Gammon, 2010 .

Re: "Quantile regression—opportunities and challenges from a user's perspective".

Ying Wei, Mary Beth Terry, M. Terry, 2015, American journal of epidemiology.

Collection of Biostatistics Research Archive

Mary Beth Terry, Manisha Desai, Marilie D. Gammon, 2010 .

The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer

Mary Beth Terry, Regina M. Santella, Jan Beyea, 2002, Breast Cancer Research and Treatment.

3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.

Jorma Isola, Gordon B Mills, Mary Beth Terry, 2009, Cancer research.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Polycyclic aromatic hydrocarbon (PAH)–DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study

Mary Beth Terry, Regina M. Santella, Hanina Hibshoosh, 2015, Cancer Causes & Control.

Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer

Mary Beth Terry, Patrick T. Bradshaw, Melanie Wall, 2015, BMC Complementary and Alternative Medicine.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Gary D. Bader, Christine L. Clarke, Gary D Bader, 2020, Nature Communications.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

Life course socioeconomic conditions, passive tobacco exposures and cigarette smoking in a multiethnic birth cohort of U.S. women

Mary Beth Terry, Parisa Tehranifar, M. Terry, 2009, Cancer Causes & Control.

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Christiana Kartsonaki, Amanda B. Spurdle, 2010, PLoS Genetics.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Assessing the goodness of fit of personal risk models

Mary Beth Terry, Alice S Whittemore, Gail Gong, 2014, Statistics in medicine.

Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer

Mary Beth Terry, K. Crew, M. Terry, 2014, International journal of cancer.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters.

Mary Beth Terry, Hui-Chen Wu, Parisa Tehranifar, 2015, American journal of epidemiology.

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

Olufunmilayo I. Olopade, Mads Thomassen, Dieter Niederacher, 2016, Breast Cancer Research.

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool

Jack Cuzick, Gord Glendon, Mary Beth Terry, 2019, JNCI cancer spectrum.

10-year performance of four models of breast cancer risk: a validation study.

Gord Glendon, Mary Beth Terry, John L Hopper, 2019, The Lancet. Oncology.

Lifetime alcohol intake and breast cancer risk.

Mary Beth Terry, Marilie D Gammon, Fang Fang Zhang, 2006, Annals of epidemiology.

Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood.

Geoffrey C Kabat, Mary Beth Terry, Steven D Stellman, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group.

Mary Beth Terry, Graham G Giles, Julian Little, 2009, Annals of epidemiology.